US negotiations for first round of drugs reveal $6bn in Medicare savings
The Biden Administration had announced the price cuts that were negotiated by the Centers for Medicare and Medicaid Services (CMS)…
All articles by Cyrus Fan
Cyrus Fan
-
-
The US Biosecure Act threatens to destabilise the pharmaceutical industry
In January this year, the US House Select Committee on the Strategic Competition between the US and the Chinese Communist…
-
First 10 drugs for Medicare price negotiation may see minimal commercial impact
The Biden Administration has released the highly anticipated list of 10 drugs selected for Medicare price negotiations under the US…
-
Minimal impact expected for first ten drugs released for Medicare price negotiation
The Biden Administration has released the highly anticipated list of ten drugs selected for Medicare price negotiations under the Inflation…
-
House Democrats unveil new legislation that expands the Inflation Reduction Act
This article is produced as part of GlobalData’s Price Intelligence (POLI) service, the world’s leading resource for global pharmaceutical pricing,…
-
Comparison of Humira biosimilars in the US and Europe
Biosimilars for AbbVie’s (US) Humira (adalimumab) have finally launched in the US, bringing an end to Humira’s 20-year reign as…
-
US midterm election results have multiple implications for the pharma industry
Although the US midterm elections have not fully concluded, it is now known who has control of each chamber of…
-
New Covid-19 antivirals priced reasonably according to ICER
For its latest high-profile review, the US Institute for Clinical and Economic Review (ICER) concluded that the three COVID-19 pills…